Skip to main content

MPSI Buys Three Thermo Rhombix Protein Crystallization Systems

NEW YORK (GenomeWeb News) - Thermo Electron said today that the Membrane Protein Structure Initiative has bought three of its Rhombix protein crystallization systems.
 
The MPSI is a consortium of eight UK universities and institutions developing high-throughput methods for crystallization and structural determination of specific membrane protein targets.
 
The Rhombix systems will be installed at the MPSI laboratories at the University of Leeds, the University of Glasgow, and the Diamond Synchroton, where the Imperial College London and Diamond are jointly establishing a membrane protein laboratory.
 
Financial details of the purchase were not disclosed.
 
The Rhombix system integrates and controls liquid-handling instrumentation and automatically handles, stores, and images plates.
 
Experimental details and automation settings are recorded and stored in a centralized database, Thermo added.
 
 

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.